Life industry goldrush
Trade in bio-industrial products is on in full swing, conjuring up visions of El dorado. But whether the Indian industry can embark on this …
Dispensing with dear drugs
New US law to clear the decks for generic drugs (Read full article)
Big blue trips up Twitter
IBM’s claim of patent violation by Twitter reflects the madness in software litigation in the US
Looming threat of a secretive trade pact
Trans-Pacific Partnership agreement will extend restrictive intellectual property laws globally
A victory and a retreat on CLs
Supreme Court upholds India's first compulsory licence but government baulks at giving the second
Patently hollow claims of the US
Global organisations and academics defend India’s IP laws and call for US to back off
Why scientists don’t back Novartis claim
As Novartis’ Indian patent case reaches end, a reminder of how scientists view unfair patents
The Smithsonian steps on the ants
Iconic museum files patent claim on fungi to control leafcutter ants—a well-known fact
Myriad gains, we all lose
The US appeals court has upheld the patents for isolated human genes, ignoring scientists’ warning that it would obstruct vital research …
WHOSE SEED IS IT ANYWAY?
The rich world’s mania for patenting seeds and pushing the UPOV agenda do not aid food security or biological diversity
A North-South conflict
BIORESOURCES AND BIOTECHNOLOGY: POLICY CONCERNS FOR THE ASIAN REGION·Edited by Suman Sahai·Gene Campaign·New Delhi, 1999&…
Beware of Policymakers
PEOPLE, PLANTS AND PATENTS: THE IMPACT OF INTELLECTUAL PROPERTY ON BIODIVERSITY, CONSERVATION, TRADE AND RURAL SOCIETY·Crucible group&…
Saying no to Monsanto
The Indian patent office has once again rejected the biotech seed giant’s claim for a method to produce stress-tolerant transgenic plants
Acta is trade terrorism
India’s generic medicines export faces a huge threat from the anti-counterfeiting law which creates barriers to global trade
Tesla's `insane' move to free up patents
The electric carmaker's decision could spur a revolution in green vehicles and in the way patents are viewed
Why do we need patents?
There is no empirical evidence that patents serve to increase innovation and productivity
Prometheus bound
The denial of a patent on a medical test that correlates drug dosages with treatment could mean the end of human gene patents
Affordable medicines row
The US pharmaceutical industry -- which has so far prevented its government from endorsing a prescription for change -- is now directly engaging …
FARM IP, ENTER WIPO
Developing countries will now have to battle IP issues related to new agricultural technologies at WIPO instead of WTO
Brickbats for compulsory licences
US criticises India and BRIC group for strengthening provisions on life-saving medicines
Japanese biopiracy of our Ballia barley
Japan’s Sapporo brewery patents Indian barley gene without giving benefit to farmers
Getting the drug equation right
Sonal Matharu reports how fights over counterfeit drugs and low-quality drugs is suppressing the larger issue of drug safety
The fine line for judges
Judges have recused themselves in a number of cases but there are no clear guidelines on what constitutes conflict of interest
Rotten tomato for Monsanto
US biotech giant's claim on a natural tomato is its latest patent to be revoked by Europe after soy and wheat
Maths of Gilead's hepatitis C drug
Why US firm's super expensive drug sofosbuvir costs so much and how it can be made at a tenth of current price